Welcome to the Stemcell Action Network

Wooden Desk

Final Victory for Patients at the Supreme Court

The US Supreme Court on Monday rejected to hear an case that would've proved to be an obstacle to government financing of human embryonic stem cell study brought forward by two scientists that stated that the United States National Institutes of Health regulations on such studies break federal law.

The choice brings an end to a claim that had threatened to hinder stem cell study after an area court judge shut out the taxpayer financing in 2010. Yet some onlookers expected the Supreme Court would decrease the take the instance after an appeals court ruled that the funding can continue.

U.S. law bans the NIH from funding the production of human embryos for study or research where human embryos are killed, but leaves area for argument over whether that also covers work with human stem cells.

Challengers of such science, including several religious traditionalists, have actually asserted that it is unwanted due to the fact that it damages human embryos.

Experts wish to be allowed to use stem cells to discover procedures for spinal cord injuries, cancer, diabetic issues and also diseases such as Alzheimer's and Parkinson's.

Amyotrophic lateral sclerosis (ALS): Progress and Promise in Stem Cell Research

The Salk Institute, and Life Technologies Corporation who aim to bring a human embryonic stem cell based ALS therapy to clinical trials within four years. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, is a progressive motor neuron disorder. Most people with ALS die within 3 to 5 years from the onset of symptoms.

Watch this video to learn about progress made on ALS research so far.